Atlas Trials

Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)

Clinical trial NCT03202147 · WITHDRAWN

Trial details

NCT number
NCT03202147
Sponsor
AZTherapies, Inc.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Ischemic StrokePost-stroke Cognitive Impairment
Start date
2023-12-01
Primary completion
2024-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.